Clinical trial
A Long-Term Continuation Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602
NCT00125879 is registered in ClinicalTrials.gov with Genzyme, a Sanofi Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Long-Term Continuation Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602
- Lead sponsor
- Genzyme, a Sanofi Company
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- June 30, 2005
- Completion date
- December 31, 2006
- Enrollment
- 16 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.